Antibiotic prophylaxis in invasive urodynamics, a Delphi consensus of the Italian Society of Urodynamics (SIUD)

Author:

Rubilotta Emanuele1ORCID,Chiarulli Elisabetta F.2,Ammirati Enrico3ORCID,Bevacqua Marianna C.4,Manodoro Stefano5ORCID,Chierchia Stefania3,Fragalà Eugenia6,Masiello Giuseppe7,Li Marzi Vincenzo8ORCID,Giammò Alessandro2,Musco Stefania9ORCID,Savoca Francesco10,Balzarro Matteo1,De Nunzio Cosimo11,De Rienzo Gaetano12ORCID,Fusco Ferdinando13ORCID,Lamberti Gianfranco14ORCID,Soligo Marco15ORCID,De Palma Luisa16,Fasano Massimo17,Carretta Anna18,Tumietto Fabio19,Finazzi‐Agrò Enrico20ORCID,Russo Eleonora21,Antonelli Alessandro1,Gubbiotti Marilena22ORCID,Sampogna Gianluca23,Spinelli Michele23,Carone Roberto24,Martino Leonardo25,Mancini Vito25ORCID,

Affiliation:

1. Department of Urology Azienda Ospedaliera Universitaria Verona Verona Italy

2. UO Urologia, ASST‐Rhodense (Rho) Milano Torino Italy

3. Neuro‐Urologia, CTO Unità spinale unipolare, Città della Salute e della Scienza Torino Italy

4. UOC Urologia Abilitata al Trapianto, Grande Ospedale Metropolitano di Reggio Calabria Milano Italy

5. UO Ostetricia e Ginecologia Ospedale San Paolo, ASST Santi Paolo e Carlo Milano Italy

6. UO Urologia Ospedale G.B. Morgagni – L. Pierantoni, AUSL Romagna Forlì Italy

7. UO Urologia Ospedale Di Venere Bari Italy

8. Unit of Urological Robotic Surgery and Renal Transplantation, Department of Experimental and Clinical Medicine, Careggi Hospital University of Florence Firenze Italy

9. Unit of Neuro‐Urology Azienda Ospedaliera Careggi Firenze Italy

10. Unit of Urology Cannizzaro Hospital Catania Italy

11. Department of Urology Sapienza University, Ospedale Sant'Andrea Roma Italy

12. Urology and Andrology Unit, Department of Emergency and Organ Transplantation University of Bari Bari Italy

13. Dep. Urology Ospedale di Caserta Caserta Italy

14. Dep. Rehabilitative Medicine Azienda USL Piacenza Piacenza Italy

15. Unit of Obstetrics and Gynecology Ospedale Maggiore Lodi Italy

16. UOC Medicina Fisica e Riabilitazione Policlinico di Bari Italy

17. UO Malattie Infettive, Ospedale Perinei, Altamura Bari Italy

18. UOC Malattie Infettive, Policlinico di Foggia Foggia Italy

19. UOC Stewardship Antimicrobica, AUSL Bologna Italy

20. Department of Surgical Sciences, Urology Unit University of Rome Tor Vergata Roma Italy

21. UO Ginecologia e Ostetricia Universitaria I Azienda Ospedaliera Universitaria Pisana Pisa Italy

22. Dep. Urology, Montevarchi Ospedale La Gruccia Arezzo Italy

23. Unipolar Spinal Unit and Neurourology Service, ASST Grande Ospedale Metropolitano Niguarda Milano Italy

24. Neurourology, Ospedale Koelliker Torino Italy

25. Urology Unit and Renal Transplantation Policlinico di Foggia, Università di Foggia Foggia Italy

Abstract

AbstractIntroductionAlthough antibiotic prophylaxis (AB) demonstrated a statistically significant reduction in bacteriuria after invasive urodynamics (UDS), no significant decrease in the incidence of urinary tract infections (UTI) has been confirmed. No absolute recommendations on the use of AB in case of relevant potential risk of UTI have been reported, though some categories of patients at increased infective probability after UDS have been recognized. The aim of this study is to report the experts' consensus on the best practice for the use of AB before UDS in the main categories of patients at potential risk of developing UTI.Materials and MethodsA systematic literature review was performed on AB before UDS in males and females. A panel of experts from the Italian Society of Urodynamics, Continence, Neuro‐Urology, and Pelvic Floor (SIUD) assessed the review data and decided by a modified Delphi method on 16 statements proposed and discussed by the panel. The cut‐off percentage for the consensus was a ≥70% of positive responses to the survey. The study was a Delphi consensus with experts' opinions, not a clinical trial involving directly patients.ResultsThe panel group was composed of 57 experts in functional urology and UDS, mainly urologists, likewise gynaecologists, physiatrists, infectivologists, pediatric urologists, and nurses. A positive consensus was achieved on 9/16 (56.25%) of the statements, especially on the need for performing AB before UD in patients with neurogenic bladder and immunosuppression. Urine analysis and urine culture before UDS are mandatory, and in the event of their positivity, UDS should be postponed. A consensus was reached on avoiding AB in menopausal status, diabetes, age, gender, bladder outlet obstruction, high postvoid residual, chronic catheterization, previous urological surgery, lack of urological abnormalities, pelvic organ prolapse, and negative urine analysis.ConclusionsAntibiotic prophylaxis is not recommended for patients without notable risk factors and with a negative urine test due to the potential morbidities that may result from antibiotic administration. However, AB can be used for risk categories such as neurogenic bladder and immunosuppression. The evaluation of urine analysis and urine culture and postponing UDS in cases of positive tests were considered good practices, as well as performing AB in the neurogenic bladder and immunosuppression.

Publisher

Wiley

Reference22 articles.

1. BonkatG BartolettiR BruyèreF et al.Guidelines Office: Smith EJ EAU Guidelines on Urological Infection. European Association of Urology;2022.

2. AngerJ LeeU AckermanAL et al.Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. American Urological Association/Canadian Urological Association/Society of Urodynamics Female Pelvic Medicine and Urogenital Reconstruction; 2022.

3. Urinary Tract Infection (Lower): Antimicrobial Prescribing.NICE Guideline;2018.https://www.nice.org.uk/guidance/ng109

4. The usefulness of antibiotic prophylaxis in invasive urodynamics in postmenopausal female subjects

5. Randomized trial of antibiotic prophylaxis for combined urodynamics and cystourethroscopy;Cundiff GW;Obstet Gynecol,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3